Loading stock data…
Modular Medical, Inc. (MODD)
$2.82-0.86 (-23.37%)
Market ClosedLast close Sep 8
Modular Medical, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Modular Medical, Inc. in the Healthcare sector is trading at $2.82 with a market capitalization of $21M. The stock is currently near its 52-week low of $1.72, remaining 60.5% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 15/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$5.68M↑ | -$7.24M↑ | -$7.83M↓ | -$6.80M↓ | -$4.98M |
| Net Income | -$6.39M↑ | -$7.36M↑ | -$7.79M↓ | -$6.70M↓ | -$4.93M |
Peer Comparison
JNJUNHPFE
Fundamentals
Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It also offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. Modular Medical, Inc. is h...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$21.44M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.07
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-217.93%
Volume
Today's trading volume
201,943
Recent News
Modular Medical Secures National PBM Contract For Pivot Insulin Pump
Commercial-stage medical device manufacturer Modular Medical Inc. (NASDAQ:MODD) recently signed a significant contract with a national U.S. pharmacy benefit manager (PBM). The agreement officially makes the company’s next-generation Pivot tubeless patch pump available through the national PBM network. The Pivot tubeless patch pump is a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal and bolus insulin delivery over a three-da
EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades
Modular Medical, Inc. (NASDAQ:MODD) on Thursday announced that the U.S. Food & Drug Administration (FDA) has cleared a set of software enhancements to its Pivot insulin delivery system. The update further expands the system’s functionality and provides users with greater flexibility and customization options in bolus dosing, an enhanced user interface (UI), and other software upgrades. In July, the company submitted to the FDA a series of software enhancements to its Pivot insulin delivery syste
EXCLUSIVE: Modular Medical Advances Commercial Rollout With First Active Users Of Pivot Insulin Pump
Modular Medical Inc., on Tuesday, announced that the first patients have completed onboarding and training and are now actively using the Pivot tubeless insulin patch pump in real-world settings. New Commercial Milestone As Patients Begin Using Pivot The milestone marks...
Why Tandem Diabetes (TNDM) Shares Are Sliding Today
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 2.5% in the afternoon session after a new competitor, Modular Medical, announced the first patient use of its Pivot tubeless insulin patch pump.
Qualcomm unveils Meta as first data center customer, shares climb
Investing.com - Qualcomm (NASDAQ:QCOM) unveiled its Dragonfly C1000 data center CPU and secured Meta Platforms as its first major customer, announcing a strategic multi-generation supply agreement at its Investor Day 2026 in New York City.